Výsledky vyhledávání - "Fractures, Bone/chemically induced"

Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism

Autor: Morten Frost, Moustapha Kassem, Jacob Stampe Frølich, Morten Steen Hansen, Michaela Tencerova

Publikováno v: Hansen, M S S, Tencerova, M, Frølich, J, Kassem, M & Frost, M 2018, ' Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism ', Basic & Clinical Pharmacology & Toxicology, vol. 122, no. 1, pp. 25–37 . https://doi.org/10.1111/bcpt.12850

The relationship between gut and skeleton is increasingly recognised as part of the integrated physiology of the whole organism. The incretin hormones gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are secreted from the inte

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2be8e2e2be80de3e864c29ccfc45a303
https://findresearcher.sdu.dk:8443/ws/files/156523501/11.07.17_MSH.pdf

Zobrazit plný text záznamu

Pantoprazole increases cell viability and function of primary human osteoblasts in vitro

Autor: Claudine Seeliger, Martijn van Griensven, Alexander T. Haug, Marina Unger, Markus Prause

Publikováno v: Injury-International Journal of the Care of the Injured, 45(8), 1156-64. ELSEVIER SCI LTD

Proton pump inhibitors (PPIs) are a class of drugs that irreversibly inhibit the H(+)/K(+)-ATPase in gastric parietal cells. Since an association between PPI use and increased fracture risk has been found, the aim of this study was to detect potentia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9eb885ed791c07fc2502c83abc34e48d
https://doi.org/10.1016/j.injury.2014.05.005

Zobrazit plný text záznamu

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study

Autor: Guy Storme, Carmel Lino Cutajar, Michel Bolla, Jean Bernard Dubois, René-Olivier Mirimanoff, Raphael Pfeffer, Cora N. Sternberg, Ignace Billiet, Jacques Bernier, Laurence Collette, Theodore H. van der Kwast, Geertjan van Tienhoven, Padraig Warde, José Lopez Torecilla, Abraham Kuten

Publikováno v: lancet oncology, 11(11), 1066-1073. Lancet Publishing Group

Background We did a randomised phase 3 trial assessing the benefit of addition of long-term androgen suppression with a luteinising-hormone-releasing hormone (LHRH) agonist to external irradiation in patients with prostate cancer with high metastatic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20538cc7113223eeb34861a476d18d39
https://doi.org/10.1016/s1470-2045(10)70223-0

Zobrazit plný text záznamu

Use of antidepressant drugs and risk of osteoporotic and non-osteoporotic fractures

Autor: B.M. Verdel, Tjeerd van Staa, Toine C. G. Egberts, Patrick C. Souverein, Hubert G. M. Leufkens, Frank de Vries

Publikováno v: Bone, 47(3), 604-9. Elsevier Science

AIM: Both tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs) have been associated with an increased risk of fractures. The serotonin transporter (5-HTT) has been located in the bone and may play a role in bone physio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::833d5736f5f429e414e6d063d1211723
https://pubmed.ncbi.nlm.nih.gov/20601295

Zobrazit plný text záznamu

How safe is the use of thiazolidinediones in clinical practice?

Autor: Rizos, C. V., Elisaf, M. S., Mikhailidis, D. P., Liberopoulos, E. N.

BACKGROUND: Thiazolidinediones (TZDs) are widely used antidiabetic drugs with proven efficacy regarding mainly surrogate markers of diabetes management. However, efficacy on surrogate markers may not always translate into benefits in clinical outcome

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10561::d1b6e99e24198956bd3cc6c79ff78e03
http://olympias.lib.uoi.gr/jspui/handle/123456789/21159

Zobrazit plný text záznamu

Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates

Autor: F. de Vries, S. M. Cockle, A. L. Cooper, T. P. van Staa, Cyrus Cooper

Publikováno v: Osteoporosis International, 20(12), 1989-98. Springer-Verlag London Ltd.

SUMMARY: Previous studies have found an association between acid suppressants and fracture risk. We assessed fracture risk in patients taking concomitant acid suppressant and bisphosphonates. Positive associations were observed for any hip and verteb

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59b40a9cb5541e9f8f80a40c374b8174
https://pubmed.ncbi.nlm.nih.gov/19333676

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání